ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,230,000 | -17.2% | 152,014 | +42.0% | 0.01% | 0.0% |
Q1 2022 | $1,485,000 | -50.4% | 107,041 | +0.3% | 0.01% | -50.0% |
Q4 2021 | $2,996,000 | -56.7% | 106,774 | -47.6% | 0.03% | -15.2% |
Q3 2021 | $6,920,000 | +70.9% | 203,608 | +105.5% | 0.03% | -15.4% |
Q2 2021 | $4,048,000 | +8.0% | 99,096 | +6.4% | 0.04% | +5.4% |
Q1 2021 | $3,748,000 | -33.1% | 93,094 | -1.7% | 0.04% | -40.3% |
Q4 2020 | $5,599,000 | +19.4% | 94,680 | -1.8% | 0.06% | -3.1% |
Q3 2020 | $4,690,000 | +267.0% | 96,462 | +265.0% | 0.06% | +204.8% |
Q2 2020 | $1,278,000 | +229.4% | 26,425 | +89.4% | 0.02% | +162.5% |
Q1 2020 | $388,000 | – | 13,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |